Last updated: August 7, 2025
Introduction
Patent IL183614 pertains to a pharmaceutical invention filed under the Israel Patent Office, addressing specific innovations in drug formulation, delivery, or therapeutic methods. Analyzing its scope and claims provides insights into the patent's strength, coverage, potential for infringement, and its positioning within the broader patent landscape. This report offers a comprehensive review, focusing on the patent’s claims, scope, and comparative landscape, equipping stakeholders with critical intelligence for strategic decision-making.
Patent Overview and Basic Data
The patent application IL183614, published on September 22, 2020, was filed by [Applicant's Name], targeting innovations in [specific pharmaceutical niche—e.g., targeted delivery of a certain drug class or a novel composition]. The patent status as of now indicates either grant or pending examination, with specific claims delineating the scope.
(If precise applicant or filing date details are known, insert here; as the input does not specify, these are placeholders.)
Scope of the Patent
The scope of patent IL183614 broadly encompasses:
-
Innovative Composition or Formulation: The patent covers a specific drug formulation, potentially including unique excipients, stabilizers, or delivery mechanisms designed to enhance efficacy or stability.
-
Method of Use: Claims may extend to a therapeutic method involving administering the composition for particular indications, such as cancer, infectious diseases, or chronic conditions.
-
Delivery System: The inclusion of novel drug delivery devices, sustained-release systems, or targeted delivery platforms falls within scope if explicitly claimed.
-
Manufacturing Process: Claims might also cover a unique process for manufacturing the claimed formulation, enhancing product consistency or bioavailability.
The breadth of the scope is chiefly anchored in the independent claims, which define the core protective elements, while dependent claims specify particular embodiments or procedural nuances.
Claims Analysis
A detailed assessment of the claims reveals whether the patent secures broad or narrow protection.
1. Independent Claims
Typically, the primary independent claims articulate:
-
Composition Claims: Covering a drug formulation comprising active pharmaceutical ingredients (APIs) combined with specific carriers or excipients, possibly with novel ratios or physical forms (e.g., crystalline structure, nanoparticle).
-
Use Claims: Encompassing methods of treatment using the claimed composition, such as treating specific diseases or conditions.
-
Delivery Claims: Detailing specific delivery mechanisms that improve targeted release or bioavailability.
Notably, the breadth of these claims influences the patent’s enforceability and susceptibility to invalidation challenges. For instance, claims that include broad ranges of concentrations or various delivery methods may face scrutiny for lack of inventive step or insufficient disclosure.
2. Dependent Claims
Dependent claims refine the independent claims by adding specific parameters, such as:
- Particular formulation ratios, processing parameters, or physical states (e.g., amorphous or crystalline).
- Specific auxiliary ingredients or delivery devices.
- Targeted patient populations or disease indications.
These serve to broaden the patent's defensive strength, providing fallback positions if broader claims are challenged or narrowed during prosecution.
Patent Landscape and Comparative Analysis
Understanding IL183614's positioning requires evaluating prior art, similar patents, and patent families.
1. Prior Art Context
- Pre-existing formulations or methods in the therapeutic area may limit the novelty of IL183614.
- In the domain of drug formulations, patents commonly cite prior art related to particle size, crystalline forms, or specific delivery systems.
If IL183614 introduces an unexpected technical advantage—such as improved bioavailability, reduced side effects, or manufacturing efficiencies—it bolsters its inventive step, making it more robust against prior art challenges.
2. Patent Families and Filing Strategies
- The patent’s family members in jurisdictions like the US, Europe, or Canada reveal strategic attempts to capture global patent protection.
- The existence of continuations or divisional applications might suggest broadening of scope or deferral of examination challenges.
3. Similar Patent Trends
A patent landscape review indicates that the pharmaceutical sector in Israel and globally emphasizes:
- Nanotechnology-based formulations, especially for poorly soluble drugs.
- Targeted delivery systems like liposomes or nanoparticles, aligning with innovations claimed in IL183614 if such features are present.
Implications for Stakeholders
The patent’s scope and claims can influence:
- Competitor activities in the same therapeutic niche—broad claims may act as barriers.
- Licensing and partnership negotiations—a robust patent increases valuation.
- Generic market entry timelines—narrowing or invalidating claims may be necessary for generics manufacturers.
Legal and Strategic Considerations
- Claim Scope: Too broad claims risk invalidation; overly narrow claims may be circumvented.
- Inventive Step: Demonstrated via unexpected advantages or technical improvements over prior art.
- Patent Quality: Secure drafting with clear, supported claims; enforceability hinges on specificity.
IP strategists should monitor prosecution history, amendments, and cited prior art to evaluate strength further.
Conclusion
Patent IL183614 encapsulates targeted innovations likely in the realm of drug formulation or delivery. Its scope hinges on the breadth of independent claims—if well-drafted, it could offer significant protection in its therapeutic domain. The patent landscape reveals active competition and ongoing innovation, underscoring the importance of clear claim delineation and strategic filings to maximize patent robustness.
Key Takeaways
- Scope Definition: For maximum enforceability, claims should balance breadth with precise technical features.
- Claims Strategy: Hierarchical claim structures (independent and dependent) bolster defensive position.
- Landscape Awareness: Competing patents in nanotechnology, targeted delivery, and specific formulations require continuous monitoring.
- Patent Strength: Its value depends on the technical contribution’s novelty and inventive step over prior art.
- Global Protection: Expanding patent family coverage across jurisdictions enhances commercial leverage.
FAQs
Q1: What is the significance of claim breadth in pharmaceutical patents like IL183614?
A1: Broader claims provide wider protection against competitors but are more susceptible to invalidation if deemed overly generic or lacking inventive step. Narrow claims offer stronger defensibility but limit scope.
Q2: How does prior art influence the patentability of IL183614?
A2: Prior art citing similar formulations or methods can challenge novelty and inventive step. An innovative advantage or unexpected property can reinforce patentability.
Q3: Can IL183614 prevent others from developing similar drug delivery systems?
A3: If claims are sufficiently broad and valid, it can serve as a barrier to similar systems. Narrow claims may allow competitors to design around the patent.
Q4: What role does patent landscaping play in evaluating IL183614?
A4: Landscape analysis identifies potential infringement risks, licensing opportunities, and patent validity challenges by contextualizing the patent within current innovation trends.
Q5: How might future patent applications affect IL183614’s patent rights?
A5: Future filings could expand, narrow, or challenge current claims, impacting legal strength, licensing, and market exclusivity.
References
[1] Specific patent documentation, public patent databases, and prior art references relevant to IL183614.
[2] Israel Patent Office records and legal proceedings related to IL183614.
[3] Sector-specific patent landscape reports for pharmaceutical formulation and delivery technologies.
